| Takeda Pharma AG - Rixubis 500 IE, Lyophilisat und Lösungsmittel zur Injektion | | 63123 | | 02 | | Rixubis 500 IE | | Lyophilisat und Lösungsmittel zur Injektion | | B02BD04 | | Coagulation Factor Ix | | 22.05.2014 | | |
| | Composition | | praeparatio sicca: nonacogum gamma 500 U.I., histidinum, natrii chloridum, calcii chloridum anhydricum, mannitolum, saccharum, polysorbatum 80, pro vitro.
Solvens: aqua ad iniectabile 5 ml. | | Packungsbestandteile | | | | | | | | | | Active Agent | Dose | additional_information |
|---|
| | 500 UI | praeparatio sicca |
| | BAG: Active Agent | Dose |
|---|
| | 500 UI |
| | | | Inactive agents |
|---|
| | | Histidine | | Mannitol | | Sodium Chloride | | Polysorbatum 80 | | Saccharum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | Set(s) | 326.70 | 376.25 | B | SL | No |
|
|
